Login with your work email address to view charts. No credit card required.
| Art Unit: | 1635 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1630 — Stem cells and cell culture and Nucleic Acid related therapy |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 506 — Combinatorial chemistry technology: method, library, apparatus 424 — Drug, bio-affecting and body treating compositions 536 — Organic compounds -- part of the class 532-570 series |
| Phone: | (703) 756-4603 |
| Email: | None |
| Location: | None |
| Title: | Pat Examnr (Biolgy) |
| Service: | 3 years |
| Grade: | GS-12 |
| 3-Year Grant rate: | 11% over 18 cases |
|---|---|
| Difficulty: | Extremely Hard |
| Difficulty Percentile: | 95th
|
With Examiner Meyering, you have a 11% chance of getting an issued patent by 3 years after the first office action. Examiner Meyering is an extremely hard examiner and in the 95th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Meyering, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Meyering's grant rate is lower than that of Art Unit 1635 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Meyering | 1.8 |
| Art Unit 1635 | 1.6 |
Examiner Meyering has granted 2 of 18 cases without any applicant-requested interviews for a grant rate of 11%.
Examiner Meyering has granted 0 of 0 cases with at least one applicant-requested interview for a grant rate of 0%.
With Examiner Meyering, conducting an interview decreases your chance of getting a patent granted by 100%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 18643870 | Digital Counting Of Individual Molecules By Stochastic Attachment Of Diverse Labels | Rejection information available with a Premium Stats subscription. See our pricing. | Patented | View |
| 18932216 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 19216307 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18970618 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18768373 | Oligonucleotides Comprising Segmented Gap Structures | Patented | View | |
| 18971273 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18932105 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18518069 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 19216250 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 19216195 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 17264713 | Methods And Compositions For Treating Cancer | Abandoned | View | |
| 18968602 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18968659 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18932368 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18970549 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18931989 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18777266 | Composition For Regulating Production Of Proteins | Abandoned | View | |
| 18582272 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18932213 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18970411 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18969769 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18969803 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18968892 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18931873 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18970559 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18968895 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 17385277 | Pharmaceutical Composition For Preventing Or Treating Cancer, Comprising Mir-324 And Tut4/7 Expression Modulators | Abandoned | View | |
| 17441189 | Chmp2a As A Regulator Of Natural Killer Cell-Mediated Activity | Abandoned | View | |
| 17432794 | Neuroprotection Of Neuronal Soma And Axon By Modulating Er Stress/upr Molecules | Patented | View | |
| 16629211 | Incorporation Of Unnatural Nucleotides And Methods Of Use In Vivo Thereof | Patented | View | |
| 18932316 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 18932265 | Composition For Regulating Production Of Interfering Ribonucleic Acid | Patented | View | |
| 17772763 | Transcription Regulatory Elements | Abandoned | View | |
| 17620358 | Hydroxymethyl-Modified Gamma-Pna Compositions And Methods Of Use Thereof | Abandoned | View | |
| 17275896 | Programming Protein Polymerization With Dna | Abandoned | View | |
| 17404989 | Antisense Oligonucleotides For Modulating Htra1 Expression | Abandoned | View | |
| 17277474 | Regulator Of Tgr5 Signaling As Immunomodulatory Agent | Abandoned | View | |
| 17277663 | Expression Vectors For Eukaryotic Expression Systems | Patented | View | |
| 18586486 | Detection Assays | Patented | View | |
| 17234455 | Method For Preventing Or Treating Cancer Using Syt11 Inhibitor | Patented | View | |
| 18610930 | Rnai Agents For Inhibiting Expression Of Complement Factor B (Cfb), Pharmaceutical Compositions Thereof, And Methods Of Use | Patented | View | |
| 17930672 | Kit For Detecting Foot-And-Mouth Disease Virus And Detection Method Thereof | Abandoned | View | |
| 17431474 | Targeting Micrornas To Overcome Drug Tolerance And Resistance | Abandoned | View | |
| 17744634 | Compositions For Intratumoral Administration And Related Methods | Abandoned | View | |
| 16909499 | Helper Plasmid For Transformation, Method For Producing Transformant Using The Same, And Transformation Method | Patented | View | |
| 17309140 | Bispecific Antisense Oligonucleotides For Dystrophin Exon Skipping | Patented | View | |
| 17057087 | Treatment Of Synucleinopathy And Animal Models Of Synucleinopathy | Abandoned | View | |
| 16970003 | Modified Adenoviruses | Patented | View | |
| 18630828 | Compositions And Methods For Enhancing Adoptive T Cell Therapeutics | Patented | View | |
| 17268592 | Methods Of Managing Nucleic Acid Replication, Expression, And Cleavage Using Crispr Associated Nucleases | Abandoned | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.